These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6392315)

  • 21. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cells.
    Panayotides P; Porwit A; Sjögren AM; Wasserman J; Reizenstein P
    Eur J Haematol; 1988 Apr; 40(4):362-7. PubMed ID: 3259192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
    Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
    Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.
    Nouri AM; Dorey E; Davis CL; Rohatiner A; Lister TA; Oliver RT
    Cancer Immunol Immunother; 1993 Jul; 37(1):47-53. PubMed ID: 8513452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive effect of direct current on cytotoxicity of human lymphocytes.
    Chudomel V; Soucek J; Hrubá A; Jerábek J; Schwarz J; Smetana K
    Neoplasma; 1989; 36(5):573-82. PubMed ID: 2812151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV; Ludwig WD; Thiel E
    Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of leukemic plasma on periodate-induced lymphocyte transformation.
    Schultz JC; Shahidi NT
    Leuk Res; 1982; 6(3):371-80. PubMed ID: 6289015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific recognition of human leukemic cells by allogeneic T cell lines.
    Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM
    Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.
    Urbanitz D; Büchner T; Pielken H; van de Loo J
    Klin Wochenschr; 1983 Oct; 61(19):947-54. PubMed ID: 6196515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.
    Fischbacher D; Merle M; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyßig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM
    Cell Commun Adhes; 2015; 22(2-6):49-65. PubMed ID: 27602789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.
    Fäldt R; Ankerst J
    Cancer Immunol Immunother; 1983; 15(2):69-77. PubMed ID: 6223693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLC-activation by acute lymphatic leukemia blasts.
    Rella W; Winterleitner H; Knapp W
    Blut; 1979 Jul; 39(1):17-25. PubMed ID: 313823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.
    Taylor GM; Fergusson WD; Harris R
    Clin Exp Immunol; 1979 Jan; 35(1):53-61. PubMed ID: 154982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.